These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5901318)

  • 21. Age-sex differences in response to antidepressant drugs.
    Raskin A
    J Nerv Ment Dis; 1974 Aug; 159(2):120-30. PubMed ID: 4850465
    [No Abstract]   [Full Text] [Related]  

  • 22. Recurrent vital depressions. A follow-up study of 56 female and 28 male patients.
    van Scheyen JD
    Psychiatr Neurol Neurochir; 1973; 76(2):93-112. PubMed ID: 4700934
    [No Abstract]   [Full Text] [Related]  

  • 23. The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
    Raskin A; Crook TH
    Psychol Med; 1976 Feb; 6(1):59-70. PubMed ID: 935298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of psychopharmacological drugs in the aged.
    Webb WL
    Geriatrics; 1971 Jun; 26(6):94-103. PubMed ID: 5087975
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapy possibilities for therapy-resistant depressions.
    Berner P; Kryspin-Exner K; Poeldinger W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):189-93. PubMed ID: 4614274
    [No Abstract]   [Full Text] [Related]  

  • 26. Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects.
    Raskin A; Crook TH
    J Psychiatr Res; 1976; 13(1):31-41. PubMed ID: 966189
    [No Abstract]   [Full Text] [Related]  

  • 27. Antianginal drugs. V. Monoamine oxidase (MAO) inhibitors.
    Fisch S
    Am Heart J; 1966 Jun; 71(6):837-8. PubMed ID: 5945147
    [No Abstract]   [Full Text] [Related]  

  • 28. The metabolism of norepinephrine in depressions. Differences and effects of therapies.
    Rosenblatt S; Chanley JD
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:50-60. PubMed ID: 5937839
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current problems of endogenous depression].
    Núnek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):93-5. PubMed ID: 5418678
    [No Abstract]   [Full Text] [Related]  

  • 30. ANTI-DEPRESSANT DRUGS.
    JACKSON D; BERNARD LA; BENTLIF P
    Med Rec Ann; 1963 Oct; 56():216-8 PASSIM. PubMed ID: 14053455
    [No Abstract]   [Full Text] [Related]  

  • 31. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 32. [CRITICAL CONSIDERATIONS ON THE PHARMACOTHERAPY OF DEPRESSION].
    VENCOVSKY E
    Cesk Psychiatr; 1963 Jun; 59():151-8. PubMed ID: 14081805
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of small electrical currents upon depressive symptoms.
    Nias DK; Shapiro MB
    Br J Psychiatry; 1974 Oct; 125(0):414-5. PubMed ID: 4609533
    [No Abstract]   [Full Text] [Related]  

  • 34. [A TEST FOR THE PHARMACOLOGICAL EVALUATION OF ANTIDEPRESSANTS].
    LAPIN IP
    Farmakol Toksikol; 1964; 27():498-501. PubMed ID: 14193130
    [No Abstract]   [Full Text] [Related]  

  • 35. Depressive illness. Identification and treatment in the elderly.
    Lippincott RC
    Geriatrics; 1968 Nov; 23(11):149-52. PubMed ID: 5682924
    [No Abstract]   [Full Text] [Related]  

  • 36. Affective disease health maintenance organization. Patterns of lithium response.
    Shelley EM; Mendlewicz J; Fieve RR
    N Y State J Med; 1974 Sep; 74(10):1766-8. PubMed ID: 4606182
    [No Abstract]   [Full Text] [Related]  

  • 37. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amitriptyline N-oxide. A new antidepressant. A clinical double-blind trial in comparison with amitriptyline].
    Godt HH; Fredslund-Andersen K; Edlund AH
    Nord Psykiatr Tidsskr; 1971; 25(3):237-46. PubMed ID: 4945956
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence-possibilities on therapy-resistant late depressions.
    Walcher W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):207-10. PubMed ID: 4614276
    [No Abstract]   [Full Text] [Related]  

  • 40. The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
    Dandiya PC; Bhargava LP
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):157-67. PubMed ID: 5709781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.